文献速递呼吸道感染呼吸危重症与机械通气

社区获得性肺炎血浆蛋白质组:病理生理、结局与10年风险

The Plasma Proteome in Community-acquired Pneumonia: Pathophysiology, Outcome, and 10-Year Risk.
PubMed 文献 · Am J Respir Crit Care Med · 2025-01-01

该研究用Olink技术检测93例普通病房CAP患者及21例健康对照的血浆蛋白质组,发现904种蛋白升高、396种降低,并与先天免疫、有丝分裂及肺/心脏来源相关;131种蛋白与临床稳定时间相关,且多数在ICU-CAP和SARS-CoV-2肺炎中与死亡关联;UK Biobank中与长临床稳定时间相关的115/124种蛋白与10年肺炎风险升高相关。

要点

  • CAP入院时血浆蛋白质组中33.8%蛋白升高、14.8%降低,主要源于肺和心脏组织。
  • 131种蛋白与临床稳定时间相关,其中124种与长临床稳定时间相关。
  • 多数临床稳定时间相关蛋白在ICU-CAP和SARS-CoV-2肺炎中与死亡相关。

核心结论

  • 公开的CAP血浆蛋白质组提供病理生理机制和组织受累信息,可能支持个体化治疗开发。

研究设计与样本

  • 衍生队列:93例普通病房CAP患者和21例健康对照,用Olink技术检测血浆蛋白质组。
  • 验证队列:ICU收治的CAP患者和SARS-CoV-2肺炎患者,跨照护场所进行Olink检测。

主要发现

  • 2,676种蛋白中,904种(33.8%)在CAP中升高,396种(14.8%)降低,1,376种(51.4%)无差异。
  • 升高蛋白与先天免疫和有丝分裂通路相关,主要来源于肺和心脏组织。
  • 131种蛋白与临床稳定时间相关,其中124种(主要与单核/巨噬细胞和RNA加工相关)与长临床稳定时间相关。
  • 在88例ICU-CAP患者中,多数临床稳定时间相关蛋白在非幸存者中较幸存者高1.4至3.5倍(P<0.05)。
  • 在305例SARS-CoV-2肺炎患者中,多数临床稳定时间相关蛋白在非幸存者中低1.16至1.35倍或高1.14至2.65倍(P<0.05)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Community-acquired pneumonia (CAP) represents a significant health burden. Objectives: We aimed to map the plasma proteome in patients with CAP and associate protein abundance with pathophysiology, tissue source, and outcome. Methods: We measured the plasma proteome of patients with CAP upon admission to a general ward using Olink technology (derivation cohort). Additional Olink measurements were performed in patients with CAP admitted to the ICU and patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia across care settings (validation cohorts). Measurements and Main Results: Of 2,676 proteins analyzed in 93 ward patients with CAP and 21 healthy control subjects, 904 (33.8%) were higher in CAP, 396 (14.8%) lower, and 1,376 (51.4%) not different. More abundant proteins were associated with innate immune and mitosis pathways and mainly originated from lung and cardiac tissue. A total of 131 proteins associated with time to clinical stability (TCS), of which 124 (primarily related to monocyte and macrophage and RNA processing) were connected with a long TCS. Most TCS-associated proteins were differentially abundant in nonsurvivors versus survivors among 88 patients with ICU-CAP (1.4- to 3.5-fold higher) and 305 patients with SARS-CoV-2 pneumonia (1.16- to 1.35-fold lower or 1.14- to 2.65-fold higher; all P < 0.05). In the general population (UK Biobank), 115 of 124 (92.7%) proteins correlated with long TCS were associated with an increased risk of pneumonia during a 10-year follow-up, whereas 6 of 7 (85.7%) proteins correlated with shorter TCS were associated with a lower risk of pneumonia. Conclusions: This now publicly available CAP plasma proteome provides information on pathophysiological mechanisms and tissue involvement and may support development of personalized therapies.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Michels, Peters-Sengers, de Brabander, et al. The Plasma Proteome in Community-acquired Pneumonia: Pathophysiology, Outcome, and 10-Year Risk. Am J Respir Crit Care Med. 2025. PMID: 40600965. doi:10.1164/rccm.202502-0325OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。